
    
      The study is a prospective randomized controlled trial about 577nm micropulse laser versus
      traditional laser coagulation therapy on acute central serous chorioretinopathy. The primary
      outcome measures is the proportion of eyes with complete absorption of subretinal fluid 3
      months after treatment.
    
  